Thomas Taapken
Member of board
Medical Science
Scibase
Sweden
Biography
Thomas joined the Board in 2017. Thomas holds a Ph. D. in organic chemistry form the Technical University of Berlin and has also studied Economics, chemistry and physics at the University of Göttingen. He is today the CFO of Medigene AG. Thomas has an extensive experience from senior positions within the Pharmaceutical industry such as CEO/CFO of Epigenomics AG where he led the company’s efforts in gaining regulatory approval for the first blood-based molecular diagnostic cancer screening test by the FDA and oversaw its subsequent introduction into the US market. Before that he worked at Sanofi and various VC-Companies in both Germany as well as the US. Current assignments: CFO at Medigene AG and member of the board at Immunic AG. Independence Thomas is independent in relation to the Company and the Company’s management and to the Company’s major shareholders
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
